Highway2Heel
Member
Great post!
Can you define "several"? Last I saw, fever was the most common symptom associated with the disease, present in something like 90% of cases. And transmission from asymptomatic cases (including lack of fever) appears to be rare. Did they have any new information to suggest otherwise?
Wow, that's news! I had only heard of the one case. Do you know if this is happening elsewhere in the world?
Any info about when Remdesivir's Phase 3 trial is expected to complete?
What's the current protocol for deciding who to test? Patient starts getting minor flu symptoms... where does it progress to (and what sort of location / travel history / contacts etc) do they have to have before tests get ordered?
Is Quest capacity-limited? Sounds like they're not, right?
Probabilistic management. Glad to see it.
It's posts like these that help restore my faith that the US healthcare system is still able to handle things competently, despite some high-profile screwups and a broken system of medical insurance coverage.
I’ll ask. Can’t promise a timely response. My take on the fever question was it was a reminder that not all cases were accompanied by fever. My wife is checking with colleagues who have a finger on the pulse of what’s happening with Remdesivir elsewhere in the world. We have a well-connected friend at GlaxoSmithKline who is checking on the Phase 3 trial. As for Quest, currently not limited in their capacity to serve but they certainly don’t want to test their upper-bound...